Chancellor A M, Slattery J M, Fraser H, Swingler R J, Holloway S M, Warlow C P
Department of Clinical Neurosciences, University Department of Medicine, Western General Hospital, Edinburgh, UK.
J Neurol. 1993 Jun;240(6):339-46. doi: 10.1007/BF00839964.
The Scottish Motor Neuron Disease Register (SMNDR) is a prospective, collaborative, population-based project which has been collecting data on incident patients since 1989. In this report we present the clinical features of 229 patients with motor neuron disease (218 sporadic and 11 familial) diagnosed in 1989 and 1990 and compare their prognosis with previous studies of survival. The overall 50% survival from symptom onset was 2.5 years (95% CI, 2.2-3.0) and 5-year survival 28% (95% CI, 20-36%). The presence of progressive bulbar palsy (PBP), either at presentation or developing during the course of the illness, significantly reduced survival and was the most important prognostic indicator. Patients who survived longer than 5 years from symptom onset did not have PBP as part of their presenting illness. The prognosis was worse for women, and this was in part related to the higher frequency of PBP in older women, but age was also an independent adverse risk factor. Differences in survival between this and previous series can probably be explained on the basis of variation in case definition and ascertainment methods.
苏格兰运动神经元病登记处(SMNDR)是一个前瞻性、合作性、基于人群的项目,自1989年以来一直在收集新发患者的数据。在本报告中,我们呈现了1989年和1990年诊断的229例运动神经元病患者(218例散发性和11例家族性)的临床特征,并将他们的预后与以往的生存研究进行比较。从症状出现起的总体50%生存率为2.5年(95%可信区间,2.2 - 3.0),5年生存率为28%(95%可信区间,20 - 36%)。首发时或病程中出现进行性延髓麻痹(PBP)显著降低生存率,是最重要的预后指标。从症状出现起存活超过5年的患者首发疾病中没有PBP。女性的预后更差这部分与老年女性中PBP的较高发生率有关,但年龄也是一个独立不良风险因素。本系列与以往系列之间生存差异可能可以根据病例定义和确定方法的差异来解释。